Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: J Urol. 2015 Sep 26;195(2):356–362. doi: 10.1016/j.juro.2015.09.075

Table 4. Prevalence of uropathogens in women with UCPPS with and without flares in VB1 and VB2.

No. (%)

Enterobacter Enterococcus Escherichia Klebsiella Proteus Pseudomonas Any Uropathogen
VB1:
 No flare (127) 0 (0) 4 (3.1) 6 (4.7) 2 (1.6) 0 (0) 1 (0.8) 12 (9.4)
 Flare (86) 0 (0) 4 (4.7) 4 (4.7) 1 (1.2) 0 (0) 1 (1.2) 7 (8.1)
 p Unadjusted - 0.574 0.9802 0.803 - 0.7818 0.7424
 p Adjusted* - 0.4996 0.8632 0.6449 - 0.7253 0.5677
VB2:
 No flare (127) 0 (0) 1 (0.8) 2 (1.6) 0 (0) 2 (1.6) 0 (0) 5 (3.9)
 Flare (83) 1 (1.2) 0 (0) 0 (0) 0 (0) 1 (1.2) 2 (2.4) 1 (1.2)
 p Unadjusted 1.000 0.7625 0.9957 - 0.9957 0.9966 0.5505
 p Adjusted* 1.000 0.6369 0.9971 - 0.9971 0.9978 0.9059

These data refer to nonculture identification technique since all subjects had standard culture sterile VB2 urine sample.

*

Adjusted for employment (employed, disabled or other) and race.